What We Look For
FOCUS
At Delta Partners, we invest in the following sectors: Technology-based Businesses and MedTech & Other Healthcare.
Within those areas, we focus on 3 critical elements of a business plan when considering it for investment: Product, Market and People.
Product: Delta invests in both product and service businesses in two distinct categories. The first are business with products/services that are difficult to replicate and are intellectual property (IP) rich. The second type may not have a clearly defensible technical advantage, but has a first mover advantage with the capacity and skill to build momentum around their offering.
Market: The market is the ‘prize’ and it must be large. We like our investments to be well-positioned in new and very rapidly growing markets where the customers have great enthusiasm for the company's products. Thus, the first trait we seek in a startup is the ability and desire to attack markets poised for rapid growth. We want to be investors in companies that can gain a large market share in large emerging markets. These companies invariably make the best investments.
People: Venture capitalists often think they build companies. We don't. Management teams build companies. Venture capitalists can help. Because of this, we look for entrepreneurs who have the ability to lead their companies through the unknown and have a thorough understanding of the task at hand.
Delta Partners' most successful entrepreneurs possess some, or all, of the following attributes.
- They have deep knowledge of the 'domain' that they are targeting.
- They are flexible in responding to changing to the needs of the market.
- They know the value of capital and instinctively understand the crucial difference that separates need from want.
- They have a single-minded conviction regarding the potential of their business.
- Their confidence is tempered by an understanding of their shortcomings.
- They address these shortcomings by hiring great people around themselves.
- They have a long rolodex in the target market.
- They have a sense of urgency.
- They know that a combination of speed and stealth will usually help them beat large companies.
- They know too that other startups can pose the greatest threat to their existence.
SIZE
For our primary fund (DEF III) investments range in size up to €4-5 million. Typically we invest €0.5 - 3 million initially (occasionally less) and grow this over the life of the investment. We invest for the long haul and look for entrepreneurs with a similar perspective. Where larger amounts are required, we work with a set of partner venture capital firms throughout Europe and the United States.
Our Seedfund can invest amounts of up to €500k and is more appropriate for less developed business propositions, often where significant product/service development is still required. However, regardless of the fund investing, we expect every one of our investee companies to target a big prize.
GEOGRAPHY
Delta Partners can invest from our primary fund (DEF III) anywhere in the European Union. Our primary markets are Ireland and the United Kingdom; however, we will invest in other countries in conjunction with local investors with whom we have a strong relationship.
Our Seedfund is reserved specifically for early-stage, high-growth opportunities in the Republic of Ireland.
Company News
- 23 April 2013:
SpineGuard raises €8.1 million ($10.5 million) in successful IPO... - 15 April 2013:
Ireland’s Genable Technologies Ltd secures Orphan Drug Designation by FDA for gene therapy product G... - 5 April 2013:
Qstream and Informa Training Partners Sign Partnership Agreement... - 5 March 2013:
Fixnetix Arrives in Canada... - 5 March 2013:
GLYSURE EARNS ISO 13485 CERTIFICATION... - 15 February 2013:
Miracor granted six additional patents for its PICSO® system... - 31 January 2013:
Digit raises US$2.5m led by Delta Partners to launch “Seamlessly Cross-Platform” games... - 28 January 2013:
Delta Partners nominated as Best Investor at the TNW Irish Startup Award... - 21 January 2013:
Fixnetix Offers Microwave Access between London and Frankfurt... - 10 January 2013:
Pricing Intelligence Firm Profitero To Provide Nielsen Clients With Online Competitor Pricing Audit... - 21 December 2012:
Xcelerator secures €1.2m in funding... - 17 December 2012:
Miracor’s PICSO® System is used for the first time under CE mark in UK... - 4 December 2012:
Miracor featured in December’s Journal of Interventional Cardiology... - 29 November 2012:
Glysure completes second closing... - 15 November 2012:
Fixnetix Deploys Market Data FPGA from NovaSparks for Asperatus Capital... - 12 November 2012:
Swrve to create 100 new jobs... - 1 November 2012:
Cleverbug wins 'best digital startup' at Eircom Spider Awards 2012... - 23 October 2012:
Spineguard featured in this month's issue of START-UP magazine... - 19 October 2012:
Interview with Cleverbug's Kealan Lennon on siliconrepublic.com... - 18 October 2012:
Cleverbug named as #14 of top 50 hottest Early Stage Startups at Dublin Web Summit... - 18 October 2012:
Delta invests in Cloudium Systems, a Limerick based technology firm... - 12 October 2012:
Delta Partners invests in Boxever a new cloud-based IT company in Dublin... - 24 September 2012:
Prepare PICSO study results published in Journal of Interventional Cardiology... - 31 August 2012:
Delta Partners Complete €2 Million Investment... - 30 August 2012:
Acceleron Selects QUMAS to Manage Regulatory Documents... - 30 August 2012:
The Next Web interviews WhipCar co-founder... - 30 August 2012:
Glucose Monitoring and the Economy... - 23 August 2012:
WhipCar co-founder presents at Media Evolution conference in Sweden... - 2 August 2012:
Glysure appoints Heidi Hausner as U.S director of Clinical Affairs... - 19 July 2012:
PediGuard® gives 30% reduction in radiation exposure... - 12 July 2012:
Glysure strengthens intellectual property portfolio with new patent and core technology acquisition... - 11 July 2012:
The Economist describes WhipCar's success... - 11 July 2012:
Benitec Biopharma signs key genetic eye disease licensing agreement with Genable Technologies... - 11 July 2012:
Neuravi welcomed to Delta's medtech portfolio... - 6 July 2012:
Miracor reports successful First-In-Man treatments using PICSO® system... - 25 June 2012:
Miracor granted several U.S. patents for its PICSO® system to treat severe heart attack patients... - 22 June 2012:
Spinal News International Profiles: Dr. Ciaran Bolger... - 21 June 2012:
RealBusines.com Profile: Peer-to-Peer Car Sharing Platform WhipCar... - 21 June 2012:
Kealan Lennon of Cleverbug featured in the Irish Times... - 29 May 2012:
Fixnetix Offers FPGA iX-eCute for Nanosecond Trading... - 24 May 2012:
Bloomberg Acquires PolarLake & Launches EDM Services... - 23 May 2012:
Private pursuits: Many banks are hoping that wealth management can restore their fortunes...
